Keywords: lam, pharma, buy, chinese, drug, firm, 14m
LAM Pharma to buy Chinese drug firm in $14M deal
Article | 17 January 2005
USA-headquartered LAM Pharmaceuticals, a biomedical company focused on the development and commercialization of novel wound-healing and transdermal drug delivery systems, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
